0 174

Cited 4 times in

High cut-off value of a chimeric TSH receptor (Mc4)-based bioassay may improve prediction of relapse in Graves' disease for 12 months

Authors
 Sena Hwang  ;  Dong Yeob Shin  ;  Mi Kyung Song  ;  Eun Jig Lee 
Citation
 ENDOCRINE, Vol.48(1) : 89-95, 2015 
Journal Title
 ENDOCRINE 
ISSN
 1355-008X 
Issue Date
2015
MeSH
Adult ; Antithyroid Agents/therapeutic use ; Biological Assay ; Female ; Graves Disease/diagnosis* ; Graves Disease/drug therapy ; Graves Disease/genetics* ; Humans ; Immunoglobulins, Thyroid-Stimulating/analysis ; Male ; Middle Aged ; Mutant Chimeric Proteins/genetics* ; Predictive Value of Tests ; Prognosis ; Receptors, Thyrotropin/genetics* ; Recurrence ; Retrospective Studies
Keywords
TSH-receptor antibody ; Mc4 bioassay ; M22 monoclonal antibody ; Graves’ disease ; Predictive value
Abstract
There are scarce reports regarding a functional prognostic value of thyroid-stimulating autoantibody (TSAb) levels using a thyroid-stimulating hormone receptor chimera (Mc4) in Graves' disease (GD) in iodine sufficient area. The aim of this study was to investigate whether Mc4-TSAb can predict GD remission/relapse after antithyroid drug (ATD) treatment and to compare Mc4-TSAb with a binding assay using M22 monoclonal antibody (M22-TRAb) in GD patients. We retrospectively reviewed the results of M22-TRAb and Mc4-TSAb in GD patients treated with ATD for 12 months. GD patients who underwent ATD treatment for at least 12 months were included. We compared the predictive values of M22-TRAb and Mc4-TSAb for GD remission and relapse. Of the 92 patients, 60 (65.2%) achieved remission and 32 (34.8%) relapsed within 12 months. In receiver operating characteristic analysis, there were no significant differences in the area under the curves (AUCs) between Mc4-TSAb [AUC=0.79 (95% CI 0.69-0.89)] and M22-TRAb [AUC=0.69 (95% CI 0.58-0.81)]. The optimal predictive cut-off values of M22-TRAb and Mc4-TSAb were 2.23 IU/L and 230%, respectively. At a high Mc4-TSAb cut-off, the better specificity of 85.0% and positive predictive value (PPV) of 69.0% were shown compared with those at the best cut-off for M22-TRAb. In conclusion, a high cut-off for an Mc4 assay may improve the predictive value of relapse with superior specificity and PPV compared with M22-TRAb in treated GD.
Full Text
http://link.springer.com/article/10.1007%2Fs12020-014-0325-8
DOI
10.1007/s12020-014-0325-8
Appears in Collections:
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Song, Mi Kyung(송미경)
Shin, Dong Yeob(신동엽) ORCID logo https://orcid.org/0000-0003-1048-7978
Lee, Eun Jig(이은직) ORCID logo https://orcid.org/0000-0002-9876-8370
Hwang, Se Na(황세나)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/139794
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse